Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Apple
AAPL
|
+$1.29B |
| 2 |
Chevron
CVX
|
+$275M |
| 3 |
Exxon Mobil
XOM
|
+$268M |
| 4 |
Tesla
TSLA
|
+$208M |
| 5 |
Microsoft
MSFT
|
+$202M |
Top Sells
| 1 |
AT&T
T
|
+$292M |
| 2 |
CERN
Cerner Corp
CERN
|
+$275M |
| 3 |
Baidu
BIDU
|
+$154M |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$148M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$47M |
Sector Composition
| 1 | Technology | 24.43% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.13% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 7.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FXLV
2851
DELISTED
F45 Training Holdings Inc.
FXLV
| $102K | ﹤0.01% |
26,063
+6,085
| +30% | +$23.8K |
|
|
EPZM
2852
DELISTED
Epizyme, Inc
EPZM
| $102K | ﹤0.01% |
69,205
+15,296
| +28% | +$22.5K |
|
|
VNET
2853
VNET Group
VNET
$2.57B
| $101K | ﹤0.01% |
16,661
-23,866
| -59% | -$145K |
|
2854
Hyster-Yale Materials Handling
HY
$634M
| $100K | ﹤0.01% |
3,094
+498
| +19% | +$16.1K |
|
2855
Seres Therapeutics
MCRB
$139M
| $100K | ﹤0.01% |
1,466
+14
| +1% | +$955 |
|
2856
Groupon
GRPN
$923M
| $99K | ﹤0.01% |
8,767
-910
| -9% | -$10.3K |
|
|
NGD
2857
New Gold Inc
NGD
$5.16B
| $98K | ﹤0.01% |
92,734
| – | – |
|
2858
Advantage Solutions
ADV
$619M
| $97K | ﹤0.01% |
25,547
+3,040
| +14% | +$11.5K |
|
2859
EVgo
EVGO
$554M
| $97K | ﹤0.01% |
+16,198
| New | +$97K |
|
2860
Greif Class B
GEF.B
$2.46B
| $97K | ﹤0.01% |
1,554
+29
| +2% | +$1.81K |
|
2861
Nano X Imaging
NNOX
$249M
| $97K | ﹤0.01% |
8,581
+402
| +5% | +$4.54K |
|
2862
Skillsoft
SKIL
$108M
| $97K | ﹤0.01% |
1,379
+557
| +68% | +$39.2K |
|
2863
Amalgamated Financial
AMAL
$859M
| $96K | ﹤0.01% |
4,849
+312
| +7% | +$6.18K |
|
|
VAPO
2864
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $96K | ﹤0.01% |
4,748
+3,640
| +329% | +$73.6K |
|
2865
IES Holdings
IESC
$7.5B
| $95K | ﹤0.01% |
3,168
-45
| -1% | -$1.35K |
|
2866
Standard BioTools
LAB
$493M
| $95K | ﹤0.01% |
59,273
+32,258
| +119% | +$51.7K |
|
2867
Lyell Immunopharma
LYEL
$246M
| $95K | ﹤0.01% |
731
+22
| +3% | +$2.86K |
|
2868
MiMedx Group
MDXG
$1.03B
| $95K | ﹤0.01% |
27,338
-941
| -3% | -$3.27K |
|
2869
The Beachbody Company, Inc. Class A Common Stock
BODI
$45.6M
| $95K | ﹤0.01% |
1,591
-76
| -5% | -$4.54K |
|
|
INBX
2870
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $95K | ﹤0.01% |
8,383
+2,892
| +53% | +$32.8K |
|
2871
Local Bounti
LOCL
$48.7M
| $94K | ﹤0.01% |
+2,272
| New | +$94K |
|
2872
Precigen
PGEN
$1.13B
| $94K | ﹤0.01% |
70,487
+6,777
| +11% | +$9.04K |
|
2873
Viridian Therapeutics
VRDN
$1.54B
| $94K | ﹤0.01% |
+8,104
| New | +$94K |
|
2874
Adicet Bio
ACET
$67.5M
| $93K | ﹤0.01% |
6,358
+4,270
| +205% | +$62.5K |
|
2875
Dream Finders Homes
DFH
$2.7B
| $91K | ﹤0.01% |
8,611
+5,296
| +160% | +$56K |
|